Envista Holdings's Cash & cash equivalent grew by 2.95 % in the Q3 2026 sequentially, faster than Current Liabilities, this led to improvement in Envista Holdings's Quick Ratio to 1.42 a new company high.

Within Medical Equipment & Supplies industry 97 other companies have achieved higher Quick Ratio than Envista Holdings in third quarter 2026. While Quick Ratio total ranking has improved so far during the Q3 2026 to 1745, from total ranking in the second quarter 2026 at 2151.

Explain Quick Ratio?
How much Cash & cash equivalents NVST�s has?
What are NVST�s Current Liabilities?

Select the Comparisons :

None ▼

Select the Ratio:

Quick Ratio ▼

None ▼

Quick Ratio ▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/NVST/financial-strength

https://api.csimarket.com/api/v1/companies/NVST/fundamentals

https://api.csimarket.com/api/v1/companies/NVST/fundamentals?mode=as_of&as_of=YYYY-MM-DD

Programmatic access for models, analytics, and integration workflows.

Explore the Financial Data API

Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery

Connect Your AI Assistant

How to Connect Your AI Assistant to CSIMarket MCP MCP Server

Access this full dataset via API

Free sample Full docs All endpoints

NVST Quick Ratio	(Oct 02 2026) Q3	(Jul 03 2026) Q2	(Apr 03 2026) Q1	(Dec 31 2025) Q4	(Sep 26 2025) Q3
Y / Y Current Liabilities Change	-0.66 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent Change	2.2 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio MRQ	1.42	Subscribe	Subscribe	Subscribe	Subscribe
NVST's Total Ranking	# 1745	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities Change	1.11 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent Change	2.95 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick Ratio third quarter 2026 Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 98
Healthcare Sector	# 576
Overall Market	# 1688

Quick Ratio Statistics
High	Average	Low
1.42	0.89	0.24
(Oct 02 2026)		(Dec 31 2019)

Financial Statements
Envista Holdings's Current Liabilities	$ 816 Millions	Visit NVST's Balance sheet
Envista Holdings's Cash & cash equivalent	$ 1,159 Millions	Visit NVST's Balance sheet
Source of NVST's Sales		Visit NVST's Sales by Geography

Cumulative Envista Holdings's Quick Ratio

NVST's Quick Ratio for the trailling 12 Months

NVST Quick Ratio	(Oct 02 2026) 12 Months	(Jul 03 2026) 12 Months	(Apr 03 2026) 12 Months	(Dec 31 2025) 12 Months	(Sep 26 2025) 12 Months
Y / Y Current Liabilities TTM Growth	-1.32 %	Subscribe	Subscribe	Subscribe	Subscribe
Y / Y Cash & cash equivalent TTM Growth	4.28 %	Subscribe	Subscribe	Subscribe	Subscribe
Quick Ratio TTM	1.38	Subscribe	Subscribe	Subscribe	Subscribe
Total Ranking TTM	# 3967	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Current Liabilities TTM Growth	-0.16 %	Subscribe	Subscribe	Subscribe	Subscribe
Seq. Cash & cash equivalent TTM Growth	0.55 %	Subscribe	Subscribe	Subscribe	Subscribe

Quick ratio ranking by company, industry and sector >> Back to NVST Financial Strength Comparisons >> Go to Compare NVST Quick Ratio to its Competitors

On the trailing twelve months basis NVST Cash & cash equivalent improved by 2.2 % in Q3 2026 year on year, while Current Liabilities rose to $816 millions, this led to increase in in Envista Holdings's Quick Ratio to 1.38, above NVST average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 200 other companies have achieved higher Quick Ratio than Envista Holdings. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2026 from 1858 to 3967.

Explain Quick Ratio?
How much Cash & cash equivalents NVST�s has?
What are NVST�s Current Liabilities?

TTM Quick Ratio Company Ranking
Within:	No.
Within the Medical Equipment & Supplies Industry	# 201
Healthcare Sector	# 892
Within the Market	# 3967

trailing twelve months Quick Ratio Statistics
High	Average	Low
1.39	0.79	0.04
(Apr 03 2026)		(Sep 27 2019)

Companies with similar Quick Ratio in the quarter ending Oct 02 2026, within Medical Equipment & Supplies Industry	Quick Ratio	Oct 02 2026 MRQ Cash & cash equivalent	Oct 02 2026 MRQ Current Liabilities
Innovative Eyewear Inc	3.86	$ 3.197 Millions	$ 0.829 Millions
Sight Sciences Inc	3.84	$ 77.402 Millions	$ 20.137 Millions
Alpha Pro Tech Ltd	3.78	$ 25.546 Millions	$ 6.750 Millions
Hyperfine Inc	3.60	$ 37.872 Millions	$ 10.532 Millions
Profound Medical Corp	3.41	$ 33.343 Millions	$ 9.771 Millions
Rxsight Inc	3.40	$ 254.683 Millions	$ 74.952 Millions
Omada Health Inc	3.23	$ 243.151 Millions	$ 75.379 Millions
Transmedics Group Inc	3.22	$ 492.962 Millions	$ 152.857 Millions
Trisalus Life Sciences Inc	3.15	$ 41.057 Millions	$ 13.014 Millions
Procept Biorobotics Corporation	3.10	$ 218.369 Millions	$ 70.353 Millions
Carlsmed Inc	3.08	$ 56.207 Millions	$ 18.237 Millions
Outset Medical Inc	3.07	$ 136.627 Millions	$ 44.453 Millions
Sharps Technology Inc	2.82	$ 7.478 Millions	$ 2.650 Millions
Edwards Lifesciences Corporation	2.81	$ 4,683.700 Millions	$ 1,664.300 Millions
Mimedx Group Inc	2.81	$ 120.791 Millions	$ 43.031 Millions
Pulse Biosciences Inc	2.74	$ 36.725 Millions	$ 13.395 Millions
Staar Surgical Co	2.73	$ 206.414 Millions	$ 75.541 Millions
Medinotec Inc	2.68	$ 2.584 Millions	$ 0.963 Millions
Glaukos Corp	2.66	$ 337.478 Millions	$ 126.726 Millions
Pulmonx Corporation	2.57	$ 53.245 Millions	$ 20.739 Millions
Beta Bionics Inc	2.48	$ 81.551 Millions	$ 32.836 Millions
Irhythm Holdings Inc	2.46	$ 560.719 Millions	$ 228.025 Millions
Genedx Holdings Corp	2.38	$ 170.118 Millions	$ 71.403 Millions
Apyx Medical Corp	2.37	$ 25.777 Millions	$ 10.870 Millions
Atricure Inc	2.23	$ 187.031 Millions	$ 83.972 Millions
Electromed Inc	2.19	$ 15.875 Millions	$ 7.261 Millions
Inspire Medical Systems inc	1.96	$ 190.803 Millions	$ 97.438 Millions
Merit Medical Systems Inc	1.90	$ 503.551 Millions	$ 265.083 Millions
Nephros Inc	1.89	$ 4.546 Millions	$ 2.409 Millions
Warby Parker Inc	1.77	$ 287.914 Millions	$ 162.226 Millions

Date modified: 2026-11-07T13:24:00+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.